Overview

Trial of EXenatide in Acute Ischaemic Stroke

Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A multicentre, randomised controlled Trial of Exenatide versus standard care in Acute Ischemic Stroke
Phase:
Phase 2
Details
Lead Sponsor:
Neuroscience Trials Australia
Collaborators:
Monash University
National Health and Medical Research Council, Australia
Treatments:
Exenatide